Effects of n-3 polyunsaturated fatty acids in the fetal pulmonary circulation

Critical Care Medicine

Volumn 39, Issue 6, 2011, Pages 1431-1438

  Houeijeh, Ali ^a,b   Aubry, Estelle ^a,b   Coridon, Hélène ^a,b   Montaigne, Karine ^a,b   Sfeir, Rony ^a,b   Deruelle, Philippe ^a,b   Storme, Laurent ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE LILLE   (France)

Author keywords

cytochrome P450 epoxygenase; DHA; EPA; n3 polyunsaturated fatty acids; pulmonary circulation

Indexed keywords

(METHYLSULFONYL) 2 (2 PROPYNYLOXY)BENZENEHEXANAMIDE; CYTOCHROME P450 INHIBITOR; INTRALIPID; LACTIC ACID; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OMEGAVEN; TETRYLAMMONIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AORTA FLOW; AORTA PRESSURE; ARTERY BLOOD FLOW; ARTICLE; BLOOD FLOWMETER; BLOOD GAS; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; FETUS; FETUS CIRCULATION; FETUS LUNG; HEART LEFT ATRIUM PRESSURE; LACTATE BLOOD LEVEL; LAMB; LUNG ARTERY; LUNG BLOOD FLOW; LUNG CIRCULATION; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; RESPIRATORY AIRFLOW; THORACOTOMY;

EID: 85027924088     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31821204fb     Document Type: Article

References (32)

1. Ziegler TR: Parenteral nutrition in the critically ill patient. N Engl J Med 2009; 361: 1088-1097.
2. Phillips SK: Pediatric parenteral nutrition: Differences in practice from adult care. J Infus Nurs 2004; 27:166-170. (Pubitemid 38569237)
3. Pontes-Arruda A, Aragao AM, Albuquerque JD: Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 2006; 34:2325-2333. (Pubitemid 44260016)
4. Singer P, Theilla M, Fisher H, et al. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 2006; 34:1033-1038.
5. Prasertsom W, Phillipos EZ, Van Aerde JE, et al. Pulmonary vascular resistance during lipid infusion in neonates. Arch Dis Childhood 1996; 74:F95-98.
6. Simopoulos AP: Essential fatty acids in health and chronic diseases. Forum Nutr 2003; 56:67-70.
7. Dubois RN, Abramson SB, Crofford L, et al. Cyclooxygenase in biology and disease. FASEB J 1998; 12:1063-1073. (Pubitemid 28418937)
8. Fer M, Dreano Y, Lucas D, et al. Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450. Arch Biochem Biophys 2008; 471: 116-125.
9. Kulas J, Schmidt C, Rothe M, et al. Cytochrome P450-dependent metabolism of eicosapentaenoic acid in the nematode Caenorhabditis elegans. Arch Biochem Biophys 2008; 472:65-75.
10. Morin C, Sirois M, Echave V, et al. Relaxing effects of 17(18)-EpETE on arterial and airway smooth muscles in human lung. Am J Physiol Lung Cell Mol Physiol 2009; 296: L130-139.
11. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989; 2:757-761. (Pubitemid 19234807)
12. Storme L, Parker TA, Kinsella JP, et al. Chronic hypertension impairs flow-induced vasodilation and augments the myogenic response in fetal lung. Am J Physiol Lung Cell Mol Physiol 2002; 282:L56-66. (Pubitemid 34654181)
13. Storme L, Rairigh RL, Parker TA, et al. In vivo evidence for a myogenic response in the fetal pulmonary circulation. Pediatr Res 1999; 45:425-431. (Pubitemid 29157778)
14. Storme L, Rairigh RL, Parker TA, et al. K- channel blockade inhibits shear stressinduced pulmonary vasodilation in the ovine fetus. Am J Physiol 1999; 276:L220-228.
15. Brand-Schieber E, Falck JF, Schwartzman M: Selective inhibition of arachidonic acid epoxidation in vivo. J Physiol Pharmacol 2000; 51:655-672. (Pubitemid 32049519)
16. Rajapakse NW, Roman RJ, Falck JR, et al. Modulation of V1-receptor-mediated renal vasoconstriction by epoxyeicosatrienoic acids. Am J Physiol 2004; 287:R181-R187. (Pubitemid 38856326)
17. Abdukeyum GG, Owen AJ, McLennan PL: Dietary (n-3) long-chain polyunsaturated fatty acids inhibit ischemia and reperfusion arrhythmias and infarction in rat heart not enhanced by ischemic preconditioning. J Nutr 2008; 138:1902-1909.
18. Calder PC: n-3 Fatty acids and cardiovascular disease: Evidence explained and mechanisms explored. Clin Sci (Lond) 2004; 107:1-11. (Pubitemid 38932191)
19. Massaro M, Scoditti E, Carluccio M.A., et al. Basic mechanisms behind the effects of n-3 fatty acids on cardiovascular disease. Prostaglandins Leukot Essent Fatty Acids 2008, 79:109-115.
20. Katz DP, Manner T, Furst P, et al. The use of an intravenous fish oil emulsion enriched with omega-3 fatty acids in patients with cystic fibrosis. Nutrition 1996; 12:334-339. (Pubitemid 26294994)
21. Ranieri VM, Suter PM, Tortorella C, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial. JAMA 1999; 282:54-61. (Pubitemid 29318933)
22. Archer SL, Johnson GJ, Gebhard RL, et al. Effect of dietary fish oil on lung lipid profile and hypoxic pulmonary hypertension. J Appl Physiol 1989; 66:1662-1673. (Pubitemid 19112972)
23. McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009; 53:1573-1619.
24. Storme L, Rairigh RL, Parker TA, et al. Acute intrauterine pulmonary hypertension impairs endothelium-dependent vasodilation in the ovine fetus. Pediatr Res 1999, 45: 575-581. (Pubitemid 29162739)
25. Archer SL, Huang JM, Hampl V, et al. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Nat Acad Sci USA 1994; 91:7583-7587. (Pubitemid 24238229)
26. Cornfield DN, Reeve HL, Tolarova S, et al. Oxygen causes fetal pulmonary vasodilation through activation of a calcium-dependent potassium channel. Proc Nat Acad Sci USA 1996; 93:8089-8094. (Pubitemid 26277170)
27. Kiss L, Schutte H, Mayer K, et al. Synthesis of arachidonic acid-derived lipoxygenase and cytochrome P450 products in the intact hu- man lung vasculature. Am J Respir Crit Care Med 2000; 161:1917-1923. (Pubitemid 30418130)
28. Pokreisz P, Fleming I, Kiss L, et al. Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling. Hypertension 2006; 47:762-770. (Pubitemid 43740249)
29. Zhu D, Effros RM, Harder DR, et al. Tissue sources of cytochrome P450 4A and 20- HETE synthesis in rabbit lungs. Am J Respir Cell Mol Biol 1998; 19:121-128. (Pubitemid 128354949)
30. Revermann M, Barbosa-Sicard E, Dony E, et al. Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats. J Hypertens 2009; 27:322-331.
31. Ye D, Zhang D, Oltman C, et al. Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calciumactivated potassium channels. J Pharmacol Exp Ther 2002; 303:768-776. (Pubitemid 35231254)
32. Lauterbach B, Barbosa-Sicard E, Wang MH, et al. Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators. Hypertension 2002, 39:609-613 (Pubitemid 34165192)